These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Epstein-Barr virus modulates host cell microRNA-194 to promote IL-10 production and B lymphoma cell survival. Harris-Arnold A; Arnold CP; Schaffert S; Hatton O; Krams SM; Esquivel CO; Martinez OM Am J Transplant; 2015 Nov; 15(11):2814-24. PubMed ID: 26147452 [TBL] [Abstract][Full Text] [Related]
9. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Allen UD; Preiksaitis JK; Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381 [TBL] [Abstract][Full Text] [Related]
10. Post-transplant lymphoproliferative disorder associated Epstein-Barr virus DNAemia after liver transplantation in children: Experience from single center. Dogan B; Sema YA; Bora K; Veysel U; Benan D; Ezgi KT; Gozde AK; Demir D; Ozsan N; Hekimgil M; Zumrut SB; Miray K; Funda C; Sema A J Med Virol; 2024 Jun; 96(6):e29767. PubMed ID: 38932460 [TBL] [Abstract][Full Text] [Related]
11. Evidence of Epstein-Barr virus heterogeneous gene expression in adult lung transplant recipients with posttransplant lymphoproliferative disorder. Zaffiri L; Frankel C; Bush EJ; Neely ML; Pavlisko EN; Mokrova IL; Luftig MA; Palmer SM J Med Virol; 2021 Aug; 93(8):5040-5047. PubMed ID: 33704812 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders in pediatric transplantation: A prospective multicenter study in the United States. Tajima T; Martinez OM; Bernstein D; Boyd SD; Gratzinger D; Lum G; Sasaki K; Tan B; Twist CJ; Weinberg K; Armstrong B; Desai DM; Mazariegos GV; Chin C; Fishbein TM; Tekin A; Venick RS; Krams SM; Esquivel CO Pediatr Transplant; 2024 Jun; 28(4):e14763. PubMed ID: 38682750 [TBL] [Abstract][Full Text] [Related]
13. Case Report: Non-negligible Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in a lung transplant recipient. Hu J; Yu YW; Han DS; Li XJ; Zhang YQ; Cai HL; Xiao YH; Zheng X Front Immunol; 2023; 14():1244534. PubMed ID: 37781359 [TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD. Sebelin-Wulf K; Nguyen TD; Oertel S; Papp-Vary M; Trappe RU; Schulzki A; Pezzutto A; Riess H; Subklewe M Transpl Immunol; 2007 Apr; 17(3):203-10. PubMed ID: 17331848 [TBL] [Abstract][Full Text] [Related]
15. A Focused Review of Epstein-Barr Virus Infections and PTLD in Pediatric Transplant Recipients: Guidance From the IPTA and ECIL Guidelines. Yamada M; L'Huillier AG; Green M J Pediatric Infect Dis Soc; 2024 Feb; 13(Supplement_1):S31-S38. PubMed ID: 38417085 [TBL] [Abstract][Full Text] [Related]
16. Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder. Holman CJ; Karger AB; Mullan BD; Brundage RC; Balfour HH Clin Transplant; 2012; 26(5):741-7. PubMed ID: 22385033 [TBL] [Abstract][Full Text] [Related]
17. Genomic variations in EBNA3C of EBV associate with posttransplant lymphoproliferative disorder. Maloney EM; Busque VA; Hui ST; Toh J; Fernandez-Vina M; Krams SM; Esquivel CO; Martinez OM JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32213705 [TBL] [Abstract][Full Text] [Related]
18. Posttransplant Lymphoproliferative Disorder in Pediatric Patients: Characteristics of Disease in EBV-seropositive Recipients. L'Huillier AG; Dipchand AI; Ng VL; Hebert D; Avitzur Y; Solomon M; Ngan BY; Yeung S; Stephens D; Punnett AS; Barton M; Allen UD Transplantation; 2019 Nov; 103(11):e369-e374. PubMed ID: 31385930 [TBL] [Abstract][Full Text] [Related]
19. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Riddler SA; Breinig MC; McKnight JL Blood; 1994 Aug; 84(3):972-84. PubMed ID: 8043879 [TBL] [Abstract][Full Text] [Related]
20. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients. Wareham NE; Mocroft A; Sengeløv H; Da Cunha-Bang C; Gustafsson F; Heilmann C; Iversen M; Kirkby NS; Rasmussen A; Sørensen SS; Lundgren JD; J Cancer Res Clin Oncol; 2018 Aug; 144(8):1569-1580. PubMed ID: 29804164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]